MarketPeel
Insider Trading Intelligence
RC

Robert Christopher Cook

SAVA
CHIEF OPERATING & LEGAL OFFICE · FILANA THERAPEUTICS, INC. · CIK 0001952028
FILING MIX · LIFETIME100%/0%
BUYS
6
SELLS
0
TOTAL VALUE
$3.72M
COMPANIES
1
ACTIVE SINCE
Oct 2022
HOLDINGS NOW
13,725
AVG SELL PX
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Robert Christopher Cook, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+17.53%+0.44%+17.08%+17.08%
14d1+100.00%+52.23%-0.59%+52.83%+52.83%
30d1+100.00%+12.71%+2.05%+10.67%+10.67%
60d1+100.00%+11.68%+2.58%+9.10%+9.10%
90d1+0.00%-28.18%+3.25%-31.43%-31.43%
180d1+0.00%-44.33%-5.13%-39.20%-39.20%
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SAVA · 13,725 shares · as of Sep 30, 2025
025,00050,00075,000100,000202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
FLOW · 6 buys / 0 sellsCOVERAGE · 12 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SAVA
FILANA THERAPEUTICS, INC.
PURCHASE
Chief Operating & Legal Office
13,725$2.91$39.9K13,725Sep 30, 2025Oct 2, 2025View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
100,000100,000Apr 17, 2025Apr 21, 2025View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
100,000100,000Sep 6, 2024Sep 9, 2024View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,00010,000May 20, 2024May 22, 2024View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,00050,000Oct 3, 2023Oct 4, 2023View →
SAVA
FILANA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
100,000$36.76$3.68M100,000Oct 28, 2022Oct 31, 2022View →
Other insiders · SAVA
Loading peer insiders…
About this filer
CIK 0001952028
ROLE
Chief Operating & Legal Office
PRIMARY
SAVA
COMPANIES
1
ACTIVE SINCE
Oct 2022
MARKETPEEL · /INSIDER/0001952028DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback